New drug cuts ‘bad’ cholesterol by 60% on average, reducing heart attack risk
Trial of 27,000 patients found that those taking drug evolocumab saw their levels of low-density lipoprotein cholesterol fall A new drug can prevent heart attacks and strokes by cutting bad cholesterol levels, scientists have found. An international trial of 27,000 …